ID

15845

Beskrivning

Stereotactic Body Radiotherapy vs Intensity-modulated Radiotherapy in Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02339701

Länk

https://clinicaltrials.gov/show/NCT02339701

Nyckelord

  1. 2016-06-15 2016-06-15 -
Uppladdad den

15 juni 2016

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0

Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Itemgroup-kommentar för :

Item-kommentar för :


Inga kommentarer

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Prostate Cancer NCT02339701

Eligibility Prostate Cancer NCT02339701

Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
histological confirmation of prostate adenocarcinoma
Beskrivning

Adenocarcinoma of prostate

Datatyp

boolean

Alias
UMLS CUI [1]
C0007112
low or intermediate risk prostate cancer patients (i.e. t1-t2c and psa 20 and gleason score < 8) with the risk of pelvic node metastasis 15% as calculated by roach's formula
Beskrivning

Prostate carcinoma Low Risk | Prostate carcinoma Intermediate Risk | TNM tumor staging system | Prostate specific antigen measurement | Gleason score | Risk pelvic lymph node Neoplasm Metastasis

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0600139
UMLS CUI [1,2]
C3538919
UMLS CUI [2,1]
C0600139
UMLS CUI [2,2]
C3640764
UMLS CUI [3]
C0475284
UMLS CUI [4]
C0201544
UMLS CUI [5]
C3203027
UMLS CUI [6,1]
C0035647
UMLS CUI [6,2]
C1280315
UMLS CUI [6,3]
C0027627
ecog performance score 0-1
Beskrivning

ECOG performance status

Datatyp

boolean

Alias
UMLS CUI [1]
C1520224
age ≥ 18
Beskrivning

Age

Datatyp

boolean

Alias
UMLS CUI [1]
C0001779
history/physical examination within 2 weeks prior to registration
Beskrivning

Physical Examination

Datatyp

boolean

Alias
UMLS CUI [1]
C0031809
able to sign informed-consent
Beskrivning

Informed consent

Datatyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with previous diagnosis of cancer other than prostate cancer and non-melanoma skin cancer.
Beskrivning

Prior diagnosis Malignant Neoplasms | Prostate carcinoma | Skin carcinoma

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0332132
UMLS CUI [1,2]
C0006826
UMLS CUI [2]
C0600139
UMLS CUI [3]
C0699893
evidence of distant metastases
Beskrivning

distant metastases

Datatyp

boolean

Alias
UMLS CUI [1]
C3258247
regional lymph node involvement
Beskrivning

Regional Lymph Node Involvement

Datatyp

boolean

Alias
UMLS CUI [1]
C1332837
previous radical surgery (prostatectomy), cryosurgery, or hifu for prostate cancer
Beskrivning

H/O: surgery Radical | Prostatectomy | Cryosurgery | High intensity focused ultrasound Prostate carcinoma

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0455610
UMLS CUI [1,2]
C0439807
UMLS CUI [2]
C0033573
UMLS CUI [3]
C0010408
UMLS CUI [4,1]
C0441583
UMLS CUI [4,2]
C0600139
previous pelvic irradiation, prostate brachytherapy, or bilateral orchiectomy
Beskrivning

Pelvis Therapeutic radiology procedure Previous | Brachytherapy to prostate | Bilateral orchiectomy

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0030797
UMLS CUI [1,2]
C1522449
UMLS CUI [1,3]
C0205156
UMLS CUI [2]
C0854662
UMLS CUI [3]
C0007347
previous hormonal therapy, such as lhrh agonists (e.g., goserelin, leuprolide) or lhrhantagonists (e.g., degarelix), anti-androgens (e.g., flutamide, bicalutamide), estrogens (e.g.des), or surgical castration (orchiectomy)
Beskrivning

Prior Hormone Therapy | Luteinizing Hormone-releasing Hormone Agonist | Goserelin | Leuprolide | Luteinizing hormone releasing hormone antagonist product | degarelix | Androgen Antagonists | Flutamide | bicalutamide | Estrogens | Diethylstilbestrol | Castration | Orchiectomy

Datatyp

boolean

Alias
UMLS CUI [1]
C1514460
UMLS CUI [2]
C1518041
UMLS CUI [3]
C0120107
UMLS CUI [4]
C0085272
UMLS CUI [5]
C1276926
UMLS CUI [6]
C1455035
UMLS CUI [7]
C0002842
UMLS CUI [8]
C0016384
UMLS CUI [9]
C0285590
UMLS CUI [10]
C0014939
UMLS CUI [11]
C0012203
UMLS CUI [12]
C0007344
UMLS CUI [13]
C0029189
unstable angina and/or congestive heart failure requiring hospitalization, transmural myocardial infarction within the last 6 months, acute bacterial or fungal infection requiring intravenous antibiotics, chronic obstructive pulmonary disease exacerbation or other respiratory illness requiringhospitalization or precluding study therapy at the time of registration
Beskrivning

Angina, Unstable | Congestive heart failure | Hospitalization | Transmural myocardial infarction | Bacterial Infections | Mycoses | Antibiotics Intravenous | COPD exacerbation | Respiration Disorders Preventing Therapy, Investigational

Datatyp

boolean

Alias
UMLS CUI [1]
C0002965
UMLS CUI [2]
C0018802
UMLS CUI [3]
C0019993
UMLS CUI [4]
C1400513
UMLS CUI [5]
C0004623
UMLS CUI [6]
C0026946
UMLS CUI [7,1]
C0003232
UMLS CUI [7,2]
C1522726
UMLS CUI [8]
C0740304
UMLS CUI [9,1]
C0035204
UMLS CUI [9,2]
C1292733
UMLS CUI [9,3]
C0949266
patients who have received prior chemotherapy.
Beskrivning

Prior Chemotherapy

Datatyp

boolean

Alias
UMLS CUI [1]
C1514457

Similar models

Eligibility Prostate Cancer NCT02339701

Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
Adenocarcinoma of prostate
Item
histological confirmation of prostate adenocarcinoma
boolean
C0007112 (UMLS CUI [1])
Prostate carcinoma Low Risk | Prostate carcinoma Intermediate Risk | TNM tumor staging system | Prostate specific antigen measurement | Gleason score | Risk pelvic lymph node Neoplasm Metastasis
Item
low or intermediate risk prostate cancer patients (i.e. t1-t2c and psa 20 and gleason score < 8) with the risk of pelvic node metastasis 15% as calculated by roach's formula
boolean
C0600139 (UMLS CUI [1,1])
C3538919 (UMLS CUI [1,2])
C0600139 (UMLS CUI [2,1])
C3640764 (UMLS CUI [2,2])
C0475284 (UMLS CUI [3])
C0201544 (UMLS CUI [4])
C3203027 (UMLS CUI [5])
C0035647 (UMLS CUI [6,1])
C1280315 (UMLS CUI [6,2])
C0027627 (UMLS CUI [6,3])
ECOG performance status
Item
ecog performance score 0-1
boolean
C1520224 (UMLS CUI [1])
Age
Item
age ≥ 18
boolean
C0001779 (UMLS CUI [1])
Physical Examination
Item
history/physical examination within 2 weeks prior to registration
boolean
C0031809 (UMLS CUI [1])
Informed consent
Item
able to sign informed-consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Prior diagnosis Malignant Neoplasms | Prostate carcinoma | Skin carcinoma
Item
patients with previous diagnosis of cancer other than prostate cancer and non-melanoma skin cancer.
boolean
C0332132 (UMLS CUI [1,1])
C0006826 (UMLS CUI [1,2])
C0600139 (UMLS CUI [2])
C0699893 (UMLS CUI [3])
distant metastases
Item
evidence of distant metastases
boolean
C3258247 (UMLS CUI [1])
Regional Lymph Node Involvement
Item
regional lymph node involvement
boolean
C1332837 (UMLS CUI [1])
H/O: surgery Radical | Prostatectomy | Cryosurgery | High intensity focused ultrasound Prostate carcinoma
Item
previous radical surgery (prostatectomy), cryosurgery, or hifu for prostate cancer
boolean
C0455610 (UMLS CUI [1,1])
C0439807 (UMLS CUI [1,2])
C0033573 (UMLS CUI [2])
C0010408 (UMLS CUI [3])
C0441583 (UMLS CUI [4,1])
C0600139 (UMLS CUI [4,2])
Pelvis Therapeutic radiology procedure Previous | Brachytherapy to prostate | Bilateral orchiectomy
Item
previous pelvic irradiation, prostate brachytherapy, or bilateral orchiectomy
boolean
C0030797 (UMLS CUI [1,1])
C1522449 (UMLS CUI [1,2])
C0205156 (UMLS CUI [1,3])
C0854662 (UMLS CUI [2])
C0007347 (UMLS CUI [3])
Prior Hormone Therapy | Luteinizing Hormone-releasing Hormone Agonist | Goserelin | Leuprolide | Luteinizing hormone releasing hormone antagonist product | degarelix | Androgen Antagonists | Flutamide | bicalutamide | Estrogens | Diethylstilbestrol | Castration | Orchiectomy
Item
previous hormonal therapy, such as lhrh agonists (e.g., goserelin, leuprolide) or lhrhantagonists (e.g., degarelix), anti-androgens (e.g., flutamide, bicalutamide), estrogens (e.g.des), or surgical castration (orchiectomy)
boolean
C1514460 (UMLS CUI [1])
C1518041 (UMLS CUI [2])
C0120107 (UMLS CUI [3])
C0085272 (UMLS CUI [4])
C1276926 (UMLS CUI [5])
C1455035 (UMLS CUI [6])
C0002842 (UMLS CUI [7])
C0016384 (UMLS CUI [8])
C0285590 (UMLS CUI [9])
C0014939 (UMLS CUI [10])
C0012203 (UMLS CUI [11])
C0007344 (UMLS CUI [12])
C0029189 (UMLS CUI [13])
Angina, Unstable | Congestive heart failure | Hospitalization | Transmural myocardial infarction | Bacterial Infections | Mycoses | Antibiotics Intravenous | COPD exacerbation | Respiration Disorders Preventing Therapy, Investigational
Item
unstable angina and/or congestive heart failure requiring hospitalization, transmural myocardial infarction within the last 6 months, acute bacterial or fungal infection requiring intravenous antibiotics, chronic obstructive pulmonary disease exacerbation or other respiratory illness requiringhospitalization or precluding study therapy at the time of registration
boolean
C0002965 (UMLS CUI [1])
C0018802 (UMLS CUI [2])
C0019993 (UMLS CUI [3])
C1400513 (UMLS CUI [4])
C0004623 (UMLS CUI [5])
C0026946 (UMLS CUI [6])
C0003232 (UMLS CUI [7,1])
C1522726 (UMLS CUI [7,2])
C0740304 (UMLS CUI [8])
C0035204 (UMLS CUI [9,1])
C1292733 (UMLS CUI [9,2])
C0949266 (UMLS CUI [9,3])
Prior Chemotherapy
Item
patients who have received prior chemotherapy.
boolean
C1514457 (UMLS CUI [1])

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial